NCT00450502View on ClinicalTrials.gov

Safety of Batracylin in Patients With Solid Tumors and Lymphomas

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

February 24, 2007

Primary Completion Date

April 24, 2011

Study Completion Date

April 24, 2011

Conditions
Neoplasms
Interventions
DRUG

Batracylin

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00450502 - Safety of Batracylin in Patients With Solid Tumors and Lymphomas | Biotech Hunter | Biotech Hunter